Racial and ethnic disparities in neuropathy development: This study found that non-Hispanic Latino patients and those identifying as “Other” race experienced a higher prevalence of peripheral neuropathy when initiated on PD-1 inhibitors. Here, PDCD1 is linked to peripheral neuropathy.